Soheila Rahgozar

11PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 30, 2026
Increased Expression of miR-326 Mediates Chemosensitivity in Pediatric Acute Lymphoblastic Leukemia Through ABCA2 and YY1 Downregulation: An Observational and Experimental Study.

|Feb 05, 2025
The molecular impact of miR-326 in acute lymphoblastic leukemia and its cross talk with P53.

Saba Shafieizadegan, Narges Aberuyi, Soheila Rahgozar

|Jan 06, 2024
Plasma-derived exosomal miR-326, a prognostic biomarker and novel candidate for treatment of drug resistant pediatric acute lymphoblastic leukemia.

Neda Saffari, Soheila Rahgozar, Elaheh Faraji

|Aug 24, 2023
GingerenoneA overcomes dexamethasone resistance by activating apoptosis and inhibiting cell proliferation in pediatric T-ALL cells.

Melika Katebi, Soheila Rahgozar, Farnoosh Kazemi

|Jan 05, 2022
Negative value of CD10-/CD34- immunophenotype in pediatric leukemia and development of a related cell line model for investigating drug resistance.

N Aberuyi, S Rahgozar

|May 03, 2021
6-Shogaol induces apoptosis in acute lymphoblastic leukaemia cells by targeting p53 signalling pathway and generation of reactive oxygen species.

Somayeh Najafi Dorcheh, Soheila Rahgozar, Daryush Talei

Pageof 2

Frequent Collaborators

1 joint publications

Somayeh Rahimi Babasheikhali

1 joint publications

Mahboubeh Mohammadi